Limitations in the use of race in the study of disease causation.

PubWeight™: 0.92‹?›

🔗 View Article (PMC 2608462)

Published in J Natl Med Assoc on July 01, 1999

Authors

R S Cooper1, V L Freeman

Author Affiliations

1: Department of Preventive Medicine and Epidemiology, Loyola University Stritch School of Medicine, Maywood, IL 60153, USA.

Articles cited by this

A gene map of the human genome. Science (1996) 14.32

The measurement of social class in epidemiology. Epidemiol Rev (1988) 11.87

Socioeconomic status and health in blacks and whites: the problem of residual confounding and the resiliency of race. Epidemiology (1997) 6.00

Socioeconomic factors and cancer incidence among blacks and whites. J Natl Cancer Inst (1991) 5.39

Cross sectional analysis of mortality by country of birth in England and Wales, 1970-92. BMJ (1997) 4.89

By how much does dietary salt reduction lower blood pressure? III--Analysis of data from trials of salt reduction. BMJ (1991) 3.47

The excess incidence of diabetic end-stage renal disease among blacks. A population-based study of potential explanatory factors. JAMA (1992) 3.01

Family history and prostate cancer risk in black, white, and Asian men in the United States and Canada. Am J Epidemiol (1995) 2.04

Black race is an adverse prognostic factor for prostate cancer recurrence following radical prostatectomy in an equal access health care setting. J Urol (1996) 1.77

Racial, ethnic, and gender variations in cancer risk: considerations for future epidemiologic research. Environ Health Perspect (1995) 0.98

Epidemiology of IDDM in black and white children in Jefferson County, Alabama, 1979-1985. Diabetes (1989) 0.89

The kidney in hypertension--villain and victim. N Engl J Med (1989) 0.87

Etiology of low-birthweight birth: a population-based study. Prev Med (1994) 0.87

Predictors of mortality from idiopathic dilated cardiomyopathy in 356,222 men screened for the Multiple Risk Factor Intervention Trial. Am J Epidemiol (1994) 0.86

Genetic characteristics of prostate cancer. Cancer Epidemiol Biomarkers Prev (1995) 0.84